Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
643 |
|
| Actual shortage: | 17 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 541 (84%) | |
Discontinuation Reports |
233 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 233 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
80 (9%) |
|
Overdue reports |
1 (6%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-ABACAVIR/LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2019-05-28 | 2019-06-19 | 85021 |
| MYLAN-MIRTAZAPINE | 15MG | TABLET | Resolved | 2019-05-28 | 2019-07-17 | 85061 |
| FREYA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2019-06-04 | 2019-06-19 | 85557 |
| MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | 600MG 300MG 200MG | TABLET | Resolved | 2019-06-25 | 2019-07-03 | 87463 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 300MG 200MG | TABLET | Resolved | 2019-07-03 | 2019-07-10 | 88291 |
| MYLAN-VERAPAMIL | 120MG | TABLET | Resolved | 2019-07-03 | 2019-10-16 | 88302 |
| MYLAN-LAMOTRIGINE | 100MG | TABLET | Resolved | 2019-07-23 | 2019-08-23 | 89824 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 300MG 200MG | TABLET | Resolved | 2019-07-29 | 2019-09-26 | 90113 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2019-08-07 | 2020-01-23 | 91044 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2019-09-17 | 2019-09-26 | 94099 |
| MYLAN-TADALAFIL | 20MG | TABLET | Resolved | 2019-09-19 | 2020-03-04 | 94402 |
| MYLAN-TADALAFIL | 5MG | TABLET | Resolved | 2019-09-26 | 2020-01-17 | 94761 |
| MYLAN-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-09-26 | 2019-10-23 | 94770 |
| MYLAN-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-09-26 | 2019-10-02 | 94773 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2019-10-01 | 2020-01-13 | 95097 |
| MYLAN-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-11-12 | 2020-01-29 | 98529 |
| MYLAN-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-11-12 | 2020-01-29 | 98534 |
| MYLAN-ACYCLOVIR | 400MG | TABLET | Resolved | 2019-11-12 | 2020-01-17 | 98539 |
| MYLAN-CILAZAPRIL | 5.0MG | TABLET | Resolved | 2019-12-19 | 2020-07-08 | 101590 |
| MYLAN-CILAZAPRIL | 2.5MG | TABLET | Resolved | 2020-01-13 | 2020-07-08 | 103157 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-07-10 | 2018-07-11 | 55141 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16009 |
| MYLAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16012 |
| MYLAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16015 |
| MYLAN-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16018 |
| MYLAN-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-06-06 | 2018-07-04 | 51653 |
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |